US Patent 7847062 Pharmacokinetic modulation and compositions for modified FN3 polypeptides

Patent 7847062 was granted and assigned to Bristol-Myers Squibb on December, 2010 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent

Patent attributes

Current Assignee

Bristol-Myers Squibb

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

78470620

Patent Inventor Names

Yan Chen0

Lin Sun0

Martin C. Wright0

Michael Wittekind0

Ai Ching Lim0

Alan S. Harris0

Elena Getmanova0

Jochem Gokemeijer0

Date of Patent

December 7, 2010

Patent Application Number

114826410

Date Filed

July 7, 2006

Patent Primary Examiner

‌

Bridget E Bunner

Patent abstract

The present disclosure relates to novel vascular endothelial growth factor receptor (VEGFR)-binding polypeptides and methods for using these polypeptides to inhibit biological activities mediated by vascular endothelial growth factors (VEGFs). The present disclosure also provides various improvements relating to single domain binding polypeptides.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 7847062 Pharmacokinetic modulation and compositions for modified FN3 polypeptides

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API